Opportunity ID: 307498

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-18-867
Funding Opportunity Title: Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.172 — Human Genome Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 23, 2018
Last Updated Date:
Original Closing Date for Applications: Jul 16, 2021
Current Closing Date for Applications: Jul 16, 2021
Archive Date: Aug 21, 2021
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Private institutions of higher education
Special district governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Genome-wide association studies and other disease studies have identified many variants that are statistically associated with disease risk, disease protection, or other traits. However, such studies do not generally show which specific variants in genomic elements cause these effects, or how they result in differences in function. Similarly, genomic sequencing studies in clinical settings have identified many variants in healthy and diseased individuals. However, the pathogenicity of such variants is often unknown, leading to their classification as variants of uncertain significance (VUS), which makes clinical implementation difficult. This Program Announcement and the companion R21 Program Announcement aim to support the development of novel and generalizable approaches to study how genetic variants lead to differences in function and to study how such functional differences affect human health and disease processes or how this knowledge can be used clinically.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-18-867.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00243961 Sep 16, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259932 Sep 16, 2018 Jul 16, 2021 View

Package 1

Mandatory forms

307498 RR_SF424_2_0-2.0.pdf

307498 PHS398_CoverPageSupplement_4_0-4.0.pdf

307498 RR_OtherProjectInfo_1_4-1.4.pdf

307498 PerformanceSite_2_0-2.0.pdf

307498 RR_KeyPersonExpanded_2_0-2.0.pdf

307498 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

307498 RR_Budget_1_4-1.4.pdf

307498 RR_SubawardBudget30_1_4-1.4.pdf

307498 PHS398_ModularBudget_1_2-1.2.pdf

307498 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

307498 RR_SF424_2_0-2.0.pdf

307498 PHS398_CoverPageSupplement_5_0-5.0.pdf

307498 RR_OtherProjectInfo_1_4-1.4.pdf

307498 PerformanceSite_2_0-2.0.pdf

307498 RR_KeyPersonExpanded_2_0-2.0.pdf

307498 PHS398_ResearchPlan_4_0-4.0.pdf

307498 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

307498 RR_Budget_1_4-1.4.pdf

307498 RR_SubawardBudget30_1_4-1.4.pdf

307498 PHS398_ModularBudget_1_2-1.2.pdf

307498 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T18:15:40-05:00

Share This Post, Choose Your Platform!

About the Author: